Jacob P. Thyssen
- Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phaseIIItrials
2020/01/30 by E.L. Simpson, Eric L. Simpson, J.‐P. Lacour +43 · 29 citations
Medicine · Immunology and Microbiology · #Dermatology and Skin Diseases #Psoriasis: Treatment and Pathogenesis #Allergic Rhinitis and Sensitization
- Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials
2022/09/09 by Eric L. Simpson, Joseph F. Merola, Jonathan I. Silverberg +13 · 27 citations
Medicine · #Dermatology and Skin Diseases #Asthma and respiratory diseases #Allergic Rhinitis and Sensitization
- Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials
2023/03/30 by Andrew Blauvelt, Jacob P. Thyssen, Jacob P Thyssen +19 · 26 citations
Medicine · Immunology and Microbiology · #Dermatology and Skin Diseases #Psoriasis: Treatment and Pathogenesis #Asthma and respiratory diseases
- Gene–Environment Interaction Affects Risk of Atopic Eczema: Population and In Vitro Studies
2025/06/04 by Marie Standl, Ashley Budu‐Aggrey, Luke Johnston +73 · 1 voice · 1 citation
Biochemistry, Genetics and Molecular Biology · Medicine · #Dermatology and Skin Diseases #Gut microbiota and health #Human-Animal Interaction Studies